| Sources | Names Used |
|---|---|
| CTRPv2 | triazolothiadiazine |
| PharmacoGx | triazolothiadiazine |
| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | CHERP | CTRPv2 | pan-cancer | AAC | 0.18 | 3e-08 |
| mRNA | ANP32B | CTRPv2 | pan-cancer | AAC | 0.19 | 3e-08 |
| mRNA | WASF1 | CTRPv2 | pan-cancer | AAC | 0.18 | 3e-08 |
| mRNA | ATP6V1G2-DDX39B | CTRPv2 | pan-cancer | AAC | 0.17 | 3e-08 |
| mRNA | CDC42EP3 | CTRPv2 | pan-cancer | AAC | -0.17 | 3e-08 |
| mRNA | LTBR | CTRPv2 | pan-cancer | AAC | -0.2 | 3e-08 |
| mRNA | ATP6V0E1 | CTRPv2 | pan-cancer | AAC | -0.18 | 4e-08 |
| mRNA | SRSF1 | CTRPv2 | pan-cancer | AAC | 0.17 | 4e-08 |
| mRNA | SERINC3 | CTRPv2 | pan-cancer | AAC | -0.17 | 4e-08 |
| mRNA | RFX3 | CTRPv2 | pan-cancer | AAC | 0.17 | 4e-08 |
